Oxford covid antibody: No reactions seen as more volunteers get Covishield in India Kumar Jeetendra | August 28, 2020 Five volunteers were given Oxford covid-19 vaccine at Pune district Thursday as part of this phase II clinical trial. Three of these volunteers have been administered the Oxford COVID-19 vaccine candidate in Bharti Vidyapeeth’s Medical College and Hospital at Pune town while two more volunteers were inoculated with the Oxford COVID-19 vaccine candidate at the …
Stage III preliminary of Oxford antibody to start in Pune one week from now Kumar Jeetendra | September 19, 2020 Pune, Sep 19 (PTI) The phase-III human clinical trial of the COVID-19 vaccine developed by Oxford University and being fabricated by the Serum Institute of India (SII) will begin at the Sassoon General Hospital in Pune next week. “The phase-III trial of”Covishield” vaccine will start in Sassoon hospital from next week. It’s likely to start …
AstraZeneca gets halfway invulnerability in ease EU antibody bargain Kumar Jeetendra | September 25, 2020 European authorities will pay claims over an agreed limit against AstraZeneca over side-effects from its potential COVID-19 vaccine, under different terms to a deal struck with Sanofi, an EU official told Reuters. The deals reflect different approaches by two of the world’s best drugmakers for protecting themselves as a debate rages about liabilities for vaccines …